Edition:
United States

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

26.78USD
21 Sep 2018
Change (% chg)

$-4.73 (-15.01%)
Prev Close
$31.51
Open
$31.51
Day's High
$31.51
Day's Low
$26.74
Volume
1,314,369
Avg. Vol
272,994
52-wk High
$35.99
52-wk Low
$16.33

Chart for

About

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that... (more)

Overall

Beta: --
Market Cap(Mil.): $1,156.91
Shares Outstanding(Mil.): 43.20
Dividend: --
Yield (%): --

Financials

  NTLA.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -2.07 -- --
ROI: -29.97 1.50 12.72
ROE: -35.51 0.19 14.85

BRIEF-Intellia Therapeutics Inc Q1 Loss Per Share $0.51

* INTELLIA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 01 2018

Earnings vs. Estimates